SCHEMBL16454853

SCHEMBL16454853

COc1ccccc1-c1nnc2c(C(=O)Nc3cc(C)cc(C)c3)cccn12

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ MAPT P10636 1/20 0.45
▸ THRB P10828 1/20 0.45
▸ KMT2A Q03164 5/20 0.44
▸ KCNK3 O14649 3/20 0.44
▸ KCNK9 Q9NPC2 3/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ TSHR P16473 2/20 0.44
▸ HTT P42858 2/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.44
▸ POLB P06746 2/20 0.43
▸ PKM P14618 1/20 0.43
▸ TP53 P04637 1/20 0.42
▸ SMO Q99835 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16454875 0.92 KCNK3 (0.53) ALDH1A1MAPTKMT2AKCNK3KCNK9
SCHEMBL16454812 0.88 MAPT (0.49) ALDH1A1CYP1A2MAPTKMT2AKCNK3
SCHEMBL16454827 0.88 IDO1 (0.48) ALDH1A1MAPTKMT2AMEN1TSHR
SCHEMBL16454829 0.86 KCNK3 (0.49) ALDH1A1MAPTKMT2AKCNK3KCNK9
SCHEMBL16454784 0.85 TSHR (0.46) ALDH1A1MAPTKMT2AMEN1TSHR
SCHEMBL16454874 0.83 ALDH1A1 (0.46) ALDH1A1CYP2C19KMT2ATSHRHTT
SCHEMBL16454809 0.83 TSHR (0.53) ALDH1A1MAPTKMT2AMEN1TSHR
SCHEMBL16454869 0.82 KMT2A (0.49) ALDH1A1MAPTKMT2AMEN1TSHR
SCHEMBL16454789 0.81 CHRNA7 (0.44) ALDH1A1MAPTKMT2AKCNK3KCNK9
SCHEMBL16454793 0.76 ABCG2 (0.48) MAPTKMT2AMEN1POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015020565-A1 SUBSTITUTED [1,2,4]TRIAZOLO[4,3-A]PYRIDINES EXHIBITING ANTAGONIST PROPERTIES TO ADENOSINE A2A RECEPTORS, AND USE THEREOF ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НЬЮВАК" (ООО "НЬЮВАК") (RU) 2015-02-12 — — WO disclosed
Send feedback